The GCDMP© Chapter “Clinical Trial Database Lock” is now open for public review until March 20, 2026.

Database Lock is one of the most defining moments in the clinical trial lifecycle. It’s where data integrity is confirmed, decisions move forward, and regulatory submissions take shape. Getting it right matters.

That’s why the GCDMP© review process depends on the CDM community of professionals and experts to share their expertise that keep these guidelines accurate, practical, and applicable.

The review process in finalizing the GCDMP© chapter is crucial to ensure:

• Accuracy and Quality: ensures each recommendation reflects real‑world, modern CDM practice.
• Diverse Perspectives: strengthens the guideline with insights from professionals across roles, systems, and geographies.
• Relevance and Usability: helps maintain content that’s actionable.
• Continuous Improvement: keeps the GCDMP© evolving as trials, tech, and expectations grow more complex.

Read more about the chapter and how to share your feedback below.